Equities

Aoti Inc

AOTI:LSE

Aoti Inc

Actions
Health CareMedical Equipment and Services
  • Price (GBX)126.00
  • Today's Change0.00 / 0.00%
  • Shares traded1.96k
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Nov 12 2024 15:27 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Aoti Inc had net income fall 191.92% from a loss of 2.80m to a larger loss of 8.19m despite a 31.06% increase in revenues from 33.51m to 43.92m. An increase in the cost of goods sold as a percentage of sales from 11.98% to 14.40% was a component in the falling net income despite rising revenues.
Gross margin85.76%
Net profit margin-18.96%
Operating margin-14.10%
Return on assets-29.55%
Return on equity-131.94%
Return on investment-41.81%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Aoti Inc fell by 3.24m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 1.45m for operations while cash used for investing totalled 1.59m.
Cash flow per share-0.0577
Price/Cash flow per share--
Book value per share0.1131
Tangible book value per share0.0455
More ▼

Balance sheet in USDView more

Aoti Inc has a Debt to Total Capital ratio of 48.12%.
Current ratio2.75
Quick ratio2.57
Total debt/total equity0.9276
Total debt/total capital0.4812
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items dropped -191.92%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
--
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.